Th e relationship between glycaemic control and coronary artery disease (CAD) in type  diabetes mellitus (TDM) is controversial. In the current cross-sectional study, we addressed the relationship between Hemoglobin Ac (HbAc) values and the need for revascularization among diabetic patients undergoing coronary angiography. A total of  consecutive patients with known TDM (age .±. years, .  women) requiring coronary angiography due to CAD symptoms were included. TDM patients were categorized into two groups based on their HbAc values:  (.) diabetics with good glycaemic control (HbAc≤ ), and  (.) diabetics with poor glycaemic control (HbAc> ). A total of  patients (.) required revascularization. Th e revascularization rate was . among TDM patients with good glycaemic control and . among TDM patients with poor glycaemic control, respectively (p=.). In a logistic regression analysis, the need for revascularization was predicted by poor glycaemic control (Odds Ratio [OR] .,  Confi dence Interval [CI] .-.; p=.) adjusted for age, gender, Body-Mass-Index and diabetes duration. Moreover, there was a linear relationship between HbAc values and number of aff ected coronary arteries (r= .; p=.). Our data suggest that there is a close association between poor glycaemic control and increased revascularization rate in TDM, which should be considered in primary and secondary prevention models.
INTRODUCTION
Type  Diabetes Mellitus (TDM) continues to be one of the most common and expensive public health problems worldwide [] . It is also a major risk factor for cardiovascular disease [] . Glycaeted hemoglobin is an integrated summary of circadian blood glucose during the preceeding - weeks, equivalent to the lifespan of erythrocytes [] , and glycaeted hemoglobin Ac (HbAc) is a useful measure of glycaemic control, which plays an important role in the management of the TDM patients. Optimal glycaemic control (defined as HbAc ≤) results in lower incidence of microvascular complications [] . There is, for instance, a well-defi ned relationship between increased HbAc levels and the incidence or worsening of diabetic retinopathy [] . However, although an association between TDM and coronary artery disease (CAD) exists (current registries estimate that approximately one-third of patients undergoing Percutaneous Coronary Intervention (PCI) have TDM [] ), there is still a lack of evidence regarding the glycaemic control and macrovascular complications, including CAD. An increasing number of CAD patients undergo PCI or Coronary Artery Bypass Grafting (CABG) with a considerable risk of relapse of the CAD in the years following the intervention [, ] . In this context, the impact of glycaemic control in these patients is controversial [, ] . In the current cross-sectional study, we aimed to address the association between glycaemic control and coronary intervention rate in a consecutive cohort of TDM patients undergoing coronary angiography due to CAD symptoms.
MATERIALS AND METHODS

Study population
Th is is a retrospective study conducted at  Mayıs Hospital, Ankara between March  and January . A total of  consecutive patients (age .±. years, . women) with known TDM undergoing coronary angiography due to CAD symptoms for decision/intervention were enrolled. TDM was defi ned as previous history of the physician diagnosed TDM based on the hospital records, or the use of an oral antidiabetic agent and/or insulin at the time of the coronary angiography. Th e patients were scheduled for coronary angiography on the basis of current guidelines for ischaemic heart disease [] and categorized into two groups based on their HbAc values obtained within the  days proceeding and  days following the coronary angiography ( within the same week): "Good glycaemic control was defi ned as HbAc≤ , and "poor glycaemic control" as HbAc>  [] . The baseline anthropometrics, smoking habits and medical history as well as medications were also obtained from the medical records.Body Mass Index (BMI) was calculated according to the formula body weight divided by height squared, and obesity was defi ned as a BMI ≥ kg/m  [] . Th e study was approved by the hospital ethical committee and conducted in conformity with the Declaration of Helsinki.
Procedure
Selective coronary angiography was performed through the femoral artery using Seldinger technique. Under use of nonionic contrast media (Iomeron /ml) standard multiangulated cinegraphies were obtained. Angiograms were assessed visually by an experienced angiographer for the diagnosis of CAD and the decision for an intervention was made by the cardiology and cardiovascular surgery team of the hospital independently of the current retrospective study design.
Blood samples
HbAc values in percentage according to the Diabetes Control and Complications Trial (DCCT) / National Glycohemoglobin Standardization Program (NGSP) were obtained on a Beckmann Coulter Olympus AU  auto analyzer using the commercially available Tina-quant hemoglobin Ac Gen. reagent with the whole blood application. We also determined lipid profile and fasting plasma glucose by standard laboratory methods.
Statistical analysis
Statistical analysis was performed using the IBM SPSS version . for Windows ® system (SPSS ® Inc., Chicago, Illinois, USA). Independent sampled T-test was used for comparison of continuous variables, and chi-square test was applied for comparison of the categorical variables. A univariate logistic regression analysis was used to address the relationship between the need for revascularization and poor glycaemic control as well as anthropomorphic and clinical variables. Corrected odds ratios (OR) was calculated from the regression coeffi cients. All ORs are presented with their  confidence intervals (CI). Moreover, univariate and multivariate linear regression analysis were also executed to evaluate the correlation between HbAc levels and the number of aff ected coronary vessels. Unstandardized coefficient (B) is presented with  CI. Results are given as mean ± SD, and categorical variables as numbers (percentages). All statistical tests were two-sided, and p-values less than . were considered signifi cant.
RESULTS
In the whole group, the majority (N=; .) of the TDM patients had poor glycaemic control with mean HbAc levels >.. There was no significant difference between the patients with good glycaemic control versus poor glycaemic control regarding age, gender, BMI, obe- (Tables  and ) . Th e TDM patients with good glycaemic control seemed to have higher usage of diuretics and angiotension II antagonists while proportionally more patients among the poor glycaemic control group were on clopidogrel therapy (Table ) . Th e mean duration of TDM was longer in the poor glycaemic control group (. vs . yrs), and those patients were more likely to be treated with insulin, or oral antidiabetics and insulin in combination. In total,  TDM patients (.) undergoing coronary angiography required revascularization. As shown in Table  , the revascularization rate was   among diabetics with good glycaemic control, while almost half of the poor glycaemic control group had two or three-vessel disease with requirement for revascularization. Th e poor glycaemic control group was predominant both within the PCI and CABG procedures.
In a logistic regression analysis, the need for revascularization was associated with age, diabetes duration, poor glycaemic control and HbAc levels but not with gender, BMI, obesity, current smoking, hypertension and blood lipid levels ( FIGURE 1. HbA1c levels in T2DM patients based on the aff ected arteries during coronary angiography
DISCUSSION
Th e main fi nding of our study was that poor glycaemic control was significantly associated with the need for revascularization in this consecutive cohort of TDM patients undergoing coronary angiography due to CAD symptoms. Our results are in accordance with several other previously published studies reporting increased risk of cardiovascular outcome in patients with uncontrolled TDM. Zoungas et al. [] demonstrated that the threshold HbAc was  for macrovascular events, moreover every  higher mean HbAc level above this threshold was associated with a  higher risk . In a study by Xu et al. [] , addressing allcause and coronary heart disease mortality in TDM patients, a higher HbAc threshold (.) came out to be predictive. A recent study showing the relationship between HbAc-levels and clinic outcomes in diabetic patients following elective stenting also had similar results; diabetic patients with poor glycaemic control were . times more at risk of developing major advance cardiovascular events than good controlled diabetic patients using the HbAc threshold of  [] . However, although an association between TDM and CAD exists, the impact of glycaemic control in these patients remains controversial [, ] . Th e predictive value of high preprocedural glycaemia levels has been reported in diabetic patients undergoing PCI, especially in the context of acute myocardial infarction [, , ] . In contrary, there is also data from larger prospective studies, suggesting the absence of the benefi t in macrovascular complications of a strict glycaemia control [] . Regarding the HbAc thresholds, Currie et al. [] found an approximately U-shaped pattern between HbAc categories and all-cause mortality, suggesting that low (.) and high (.) mean HbAc levels were associated with increased all-cause mortality when compared with those having modest glucose control (.) . Th e reason for the increased mortality in low mean HbAc values remains unknown. An association with higher rates of severe hypoglycaemia was reported in the ACCORD study [] . It should also be kept in mind that the controversies within glycaemic control in literature refer mainly to the CAD cohorts. Kauff man et al. [] suggested that in a closely monitored setting, with aggressive control of cardiac risk factors and implementation of secondary prevention therapies, HbAc values at the time of an incident cardiac event may not be predictive of a recurrent cardiac event in patients with CAD. It has also been suggested that care of patients with CAD should focus primarily on management of cardiovascular risk factors, rather than improvement of suboptimal HbAc values at the time of the cardiac event [] .
The prognostic value of glycaemic control in TDM patients in respect of incident CAD also needs to be better defined. Less is known regarding the association between glycaemic control and the need for coronary revascularization among TDM patients with CAD symptoms. To the best of our knowledge, our cross-sectional study is the fi rst to address this relationship in a consecutive TDM cohort undergoing coronary angiography for suspicion of CAD. Based on the previous reports and the current guidelines of the American Diabetes Association, we also chose HbAc < as the threshold for good glycaemic control. Th e univariate predictors of the need for revascularization were age, diabetes duration, poor glycaemic control and HbAc levels but not gender, BMI, obesity, current smoking, hypertension and blood lipid levels in this cohort. However, there was a tendency for increased risk for revascularization in males, which also came out to be signifi cant in the multivariate model. Th e given HbAc threshold seemed to be suggestive for our hypothesis, and there was a positive dose-response relationship between HbAc levels and the number of aff ected coronary arteries. Our study is not without limitations. Our patients were required to have only one HbAc value for inclusion in the study, which reflects ambient mean glycaemia over - months period in relation to the angiographic procedure. A longer period over  year with several HbAc controls could have been much better to reflect the real relationship. Due to the retrospective character of our study, we did not have complete data regarding earlier HbAc values as many of those patients were referred for coronary angiography from centers other than our own hospital. As many patients with TDM have symptoms suggestive of CAD, and suspicious exercise stress testing or myocardial perfusion scintigraphy fi ndings, the negative coronary angiography results do not exclude coronary microangiopathy [] . However, our findings have clinical implications in predicting the need for coronary revascularization among TDM patients based on the glycaemic control.
CONCLUSION
In conclusion, our data suggest that there is a close association between poor glycaemic control, based on the HbAc threshold of , and the need for revascularization in TDM, which should be considered in primary and secondary cardiovascular prevention models.
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